C-反应蛋白检测在急性冠脉综合征中的诊断价值
被引量:1
摘要
目的C-反应蛋白(CRP)是最常用的炎症指标,急性冠脉综合征(ACS)病程中观察CRP的变化,以了解CRP同动脉粥样硬化进展的关系。方法对40例ACS患者于入院时、1周、1个月时,分别测CRP,对照组是30例体检健康志愿者。结果ACS患者组CRP值明显高于对照组(P<0.05)。结论CRP可能是动脉粥样硬化病变进展过程中反映疾病演进的重要标志。
出处
《黑龙江医学》
2005年第7期529-529,共1页
Heilongjiang Medical Journal
参考文献7
-
1Cesari M,Penninx B W,Newman A B,et al.Inflammatory makers and onset of cardivascular events results from the Health ABC study[J].Circulation,2003,108(19):2317~22.
-
2Harb T S,Zareba W,Moss A J.Association of C-reactive protein and serum amyloid A with recurrent coronary events in stable patients after healing of acute myocardial infarction[J].AM J Cardiol,2002,89:216~221.
-
3Allen P B,Russell P T,Frank K,et al.Elevated C-reactive protein values and atherosclerosis in sudden coronary death:Association with different pathologyies[J].Circulation,2002,17:2019~2029.
-
4Tomoda H,Aoki N.Prognostic value of C-reactive protein levels within six hours after onset of acute mvocardial infaction[J].Am Heart J,2000,140:324~328.
-
5Biasucci L M,Liuzzo G,Angiolillo D J,et al.Inflammation and actue coronary syndromes[J].Herz,2002,25(2):108~122.
-
6郭毅,姜昕,陈实,赵宏文,古坤毅.缺血性脑卒中预后与C反应蛋白水平变化的关系(英文)[J].中国临床康复,2004,8(4):753-755. 被引量:8
-
7陈忠,马根山,黄峻,朱铁兵,杨志健,王连生,曹克将.早发冠心病患者血浆C反应蛋白与临床表型及冠状动脉病变的关系[J].中国临床康复,2004,8(36):8195-8197. 被引量:5
二级参考文献15
-
1Nakagomi A, Freedman SB, Geczy CL. Interferon-gamma and lipopolysaccharide potentiate monocyte tissue factor induction by C-reactive protein: relationship with age, sex, and hormone replacement treatment. Circulation 2000; 101:1785 -91
-
2Ridker PM, Cushman M, Stampfer MJ, et al. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 1997; 336:973 - 9
-
3Ridker PM, Hennekens CH, Buring JE, et al. C-reactive protein and other markers of inflammation in the prediction of cardio-vascular disease in women. N Engl J Med 2000; 342:836 -43
-
4Cesari M, Penninx BW, Newman AB, et al. Inflammatory markers and onset of cardiovascular events: results from the Health ABC study. Circulation 2003; 108(19): 2317-22
-
5Grewal J, Chan S, Frohlieh J, et al. Assessment of novel risk factors in patients at low risk for cardiovascular events based on Framingham risk stratification. Clin Invest Med 2003; 26 (4): 158 - 65
-
6Ridker PM, Glyrm RJ, Hennekens CH. C-reactive protein adds to the predictive value of total and HDL cholesterol in determining risk of first myocardial infarction. Circulation 1998: 97:2007 - 11
-
7Ryan TJ, Faxon DP, Gunnar RM, et al. Guidelines for percutaneous transluminal coronary angioplasty. J Am Coll Cardiol 1988; 12:529 -45
-
8Haverkate F, Thompson SG, Pyke SD, et al. Production of C-reactive protein and risk of coronary events in stable and unstable angina: European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group. Lancet 1997; 349:462 - 6
-
9Anderson JL, Carlquist JF, Muhlestein JB, et al. Evaluation of C-reactive protein,an inflmmatory marker, and infectious serology as risk factors for coronary artery disease and myocardial infarction. J Am Coll Cardiol 1998; 32:35 -41
-
10Luc G, Bard JM, Juhan-Vague I, et al. C-reactive protein, interleukin-6, and fibrinogen as predictors of coronary heart disease: the PRIME Study. Arterioscler Thromb Vasc Biol 2003; 23(7): 1255 -61
共引文献11
-
1郭毅,周志斌,李富康,马可夫,王晓萍.血清基质金属蛋白酶9水平与脑梗死病灶大小及近期预后的关系(英文)[J].中国临床康复,2004,8(28):6235-6237. 被引量:3
-
2郭毅,姜昕,左彦方,周志斌,唐冰杉,李富康.基质金属蛋白酶9和转化生长因子β1在人冠状动脉斑块的表达及其与粥样斑块稳定性的关系[J].中国临床康复,2005,9(3):58-60. 被引量:4
-
3李鹏飞.C-反应蛋白的临床意义[J].中国全科医学,2005,8(6):504-505. 被引量:32
-
4赖晓辉,张清华,蒋知新,高德路,张金树.动脉粥样硬化发生过程中C反应蛋白对内皮细胞功能的影响:量效与时效趋势[J].中国临床康复,2005,9(19):48-49. 被引量:1
-
5李月华,徐琛华,董利军,刘晓红,姜坚.冠心病患者临床表现、血压及血脂水平与血清C反应蛋白的关系[J].中国临床康复,2005,9(27):36-37. 被引量:5
-
6王清华,许业松,储照虎,方芳,王新,杨倩.神经促通技术治疗脑血管疾病功能综合评定与超敏C反应蛋白的关系[J].实用医学杂志,2008,24(4):534-536. 被引量:1
-
7栗君,刘伏元.动脉粥样硬化后血管舒缩功能的改变[J].心血管康复医学杂志,2009,18(5):501-504. 被引量:9
-
8田野,孙淑梅,钟照华,黄建林,赵铁强,李春江,孟繁超,鲁凤民,叶鸿瑁.柯萨奇病毒B组3型VP1基因真核表达重组质粒诱导小鼠中和抗体反应[J].哈尔滨医科大学学报,1999,33(5):333-335.
-
9鲁明,高炎,王宁夫,李虹,郭士遵,钟益刚.不同性别早发冠心病患者临床危险因素对比分析[J].浙江医学,2012,34(6):446-448. 被引量:8
-
10尹江涛,陈民,刘瑜,张泽.老年冠心病患者血压及血糖与血清C反应蛋白的关系[J].辽宁中医药大学学报,2013,15(3):192-194. 被引量:1
同被引文献9
-
1徐晓东,刘建平,刘珉.低密度脂蛋白胆固醇/高密度脂蛋白胆固醇、甘油三酯/高密度脂蛋白胆固醇和尿酸与冠心病的关系[J].临床心电学杂志,2004,13(2):121-122. 被引量:6
-
2唐小龙,江振友,蔡淑玉,董军,肖瑞,卢燕茹.IL-6下调血管内皮细胞组织因子抑制物表达[J].第二军医大学学报,2005,26(2):147-150. 被引量:6
-
3唐小龙,江振友,董军,刘小澄,蔡淑玉,肖瑞,卢燕茹.IL-6对血管内皮细胞活性及TFmRNA表达的影响[J].四川大学学报(医学版),2006,37(2):234-237. 被引量:5
-
4Novo G,Assennato P,Caruso M,et al.Clinical significance of macrophage colony stimulating factor levels in acute coronary syndrome[J].Minerva Cardioangiol,2009,57(1):7-11.
-
5Ndrepepa G,Braun S,Iijima R,et al.Total leucocyte count,but not C-reactive protein,predicts 1-year mortality in patients with acute coronary syndromes treated with percutaneous coronary intervention[J].Clin Sci (Lond),2009,116(8):651-658.
-
6Senturk T,Sarandol E,Gullulu S,et al.Serum arylesterase activity is negatively correlated with inflammatory markers in patients with acute coronary syndromes[J].Saudi Med J,2009,30(3):334-339.
-
7Takano M,Mizuno K,Okamatsu K,et al.Mechanical and structural characteristic of vulnerable plaques:analysis by coronary angioscopy and intravascular ultrasound[J].J Am Coll Cardiol,2001,38(1):99-104.
-
8Woods A,Brull D J,Humphries S E,et al.Genetics of inflammation and risk of coronary artery disease:the central role of interleukin-6[J].Eur Heart J,2000,21 (19):1 574-1 583.
-
9Narain V S,Gupta N,Sethi R,et al.Clinical correlation of multiple biomarkers for risk assessment in patients with acute coronary syndrome[J].Indian Heart J,2008,60(6):536-542.
二级引证文献5
-
1周军,邓桂元,杨天伦,马琦琳,罗秀菊.急性冠状动脉综合征患者血浆IL-18水平与全球急性冠状动脉事件注册评分的相关性[J].中南大学学报(医学版),2014,39(6):570-576. 被引量:8
-
2许爱华,李元红,及心.白介素-18在急性心肌梗死患者冠脉血管病变中的浓度表达及临床意义探讨[J].临床和实验医学杂志,2011,10(23):1824-1825. 被引量:1
-
3宁魏青,吴洁,浦丹华.不同类型冠心病中MCP-1变化的Meta分析[J].南京医科大学学报(自然科学版),2012,32(1):136-140. 被引量:1
-
4李华.冠心病血清脂蛋白相关磷脂酶和白介素-18的改变及临床意义[J].中国伤残医学,2013,21(9):297-298. 被引量:1
-
5张辉,包玉娟,左祥荣.炎症与右心衰竭的研究进展[J].中华危重病急救医学,2018,30(8):815-818. 被引量:11
-
1江淑.急性冠脉综合征病程中C-反应蛋白检测的临床意义[J].临床医学,2004,24(1):10-11. 被引量:1
-
2韩红梅,李淑翠,邵艳萍.C-反应蛋白检测在冠心病患者中的临床意义[J].医学检验与临床,2004,16(4):55-55.
-
3梁展华.冠心病患者血浆纤维蛋白原与C-反应蛋白检测的临床意义[J].中国医药指南,2013,11(20):535-535. 被引量:3
-
4汤慧华,颉玉欣.C—反应蛋白检测对心血管疾病的临床初步探讨[J].中国实验临床免疫学杂志,1990,2(5):23-24. 被引量:6
-
5张禹,李亚南.C-反应蛋白检测对消化性疾病的诊断价值[J].人民军医,1994,37(12):23-24.
-
6郭乐,曹琳,卢琼.降钙素原及C-反应蛋白应用于肺结核治疗的临床分析[J].大家健康(学术版),2016(11):161-162.
-
7林曙光,余细勇.心衰的分子生物学与演进中的治疗策略[J].广东医学,1998,19(2):83-85. 被引量:1
-
8高凌宇.急性冠脉综合征患者高敏C-反应蛋白检测的临床观察[J].现代诊断与治疗,2014,25(21):4932-4933.
-
9洪凤芹.冠心病患者主要生化指标及C-反应蛋白检测的临床意义[J].中国基层医药,2009,16(12):2131-2132. 被引量:3
-
10陈小裕.不同类型冠心病患者血尿酸、纤维蛋白原水平变化及意义[J].中外医学研究,2010,8(18):32-33. 被引量:2